Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Hikma to buy Boehringer's U.S. generics unit for $2.65 billion
28 Jul 2015 at 12:25am
(Reuters) - Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim's U.S. specialty generic drugs business for about $2.65 billion in cash and stock to bolster its presence in the United States. Hikma said it will pay about $1.18 billion in cash and issue 40 million new Hikma shares, or about 16.71 per cent of its issued share capital, for Boehringer's Roxane Laboratories Inc and Boehringer Ingelheim Roxane Inc on closing of the deal. The Jordanian company, which makes and markets branded and non-branded generics and injectable drugs, said the deal would make it the sixth biggest U.S. generics provider.
Sanofi links with Regeneron in $2.2 billion cancer drug push
27 Jul 2015 at 11:44pm
(Reuters) - French drugmaker Sanofi said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals in the hot area of cancer immunotherapy. Sanofi will make an upfront payment of $640 million to Regeneron and the U.S. biotech company will get up to $375 million more if certain sales targets are hit. Sanofi will also invest more than $1 billion in research for the program, which aims to tap the body's immune system to help fight cancer. ...
South Korea declares end to MERS outbreak
27 Jul 2015 at 11:17pm
South Korea on Tuesday declared the effective end to a deadly outbreak of Middle East Respiratory Syndrome (MERS) that killed 36 people, triggered widespread panic and stymied growth in Asia's fourth-largest economy. Addressing a meeting of government officials in Seoul, Prime Minister Hwang Kyo-Ahn said the danger posed by what was the biggest outbreak of the virus outside Saudi Arabia was over. "I ask the public to shake off all concerns over MERS and to resume normal daily activities, including economic, cultural, leisure and school activities," he added.
Athletics-Indian Chand cleared to compete after CAS ruling
27 Jul 2015 at 10:52pm
Indian sprinter Dutee Chand feels her life is back on track after being cleared to race following the Court of Arbitration for Sport's (CAS) ruling on gender testing guidelines. The Lausanne-based court suspended the governing International Association of Athletics Federations' (IAAF) regulations regarding hyperandrogenism, a condition which produces high testosterone levels, for two years. "When I heard that CAS had allowed me to participate again in international meets, I felt like I got my life back," Chand, the under-18 national champion over 100 metres, told the Indian Express newspaper.
South Korea declares country effectively out of MERS danger
27 Jul 2015 at 9:17pm
South Korea declared on Tuesday it is effectively out of danger from Middle East Respiratory Syndrome (MERS), more than two months after the first case was reported and began spreading in hospital settings to kill 36 people. It was traced to a man who returned from a business trip to the Middle East in May. "It is the assessment of the government and the medical community that the public can rest easy," Prime Minister Hwang Kyo-ahn told a government meeting on public health. Twelve people remain hospitalized in South Korea and under treatment for MERS although only one is still testing positive for the MERS virus, the Health Ministry said, adding that no new cases have been reported since July 4.
Oregon sheriff treated after 20 suspicious envelopes found across state
27 Jul 2015 at 7:54pm
The FBI is investigating at least 20 letters received by law enforcement agencies across Oregon on Monday after a rural sheriff was hospitalized following exposure to an unidentified white powder in an envelope, officials in the state said. Sheriff Glenn Palmer of Grant County was exposed to an unknown "chemical substance" after opening a letter delivered to his office, a department dispatcher said. Palmer was hospitalized after developing a rash and was being treated early Monday evening, said Eric Schmidt, communications manager for the Association of Oregon Counties.
Correction: Smoltz-Tommy John Surgery story
27 Jul 2015 at 7:13pm
In a story July 2 about John Smoltz's induction into the Baseball Hall of Fame, The Associated Press reported erroneously that he would be the first player enshrined into the Hall following Tommy John surgery. Smoltz is the first pitcher to enter the Hall who had the operation.
U.S. Navy investigates report of cancer cluster at Guantanamo
27 Jul 2015 at 3:41pm
The U.S. Navy is investigating a complaint that seeks the evacuation of civilian and military lawyers from parts of the U.S. base in Guantanamo Bay, Cuba, following reports of cancer cases among personnel working on the trials of detainees there. At least seven civilians and military members who worked on detainee trials at Guantanamo Bay have been diagnosed with cancer, according to the complaint, which was filed with the U.S. Defense Department?s Office of the Inspector General. The complaint claims that an unusually large number of relatively healthy and young people who worked at the base have been diagnosed with cancer.
Data analyses back Sanofi dengue vaccine
27 Jul 2015 at 3:25pm
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday. The experimental drug allowed 80.8 percent of children aged nine and older to avoid hospitalization, according to three trials analyzed by the New England Journal of Medicine. For younger children, those less than nine years old, vaccine efficacy was 56.1 percent.
Colorado movie gunman's sister sobs, says she still loves him
27 Jul 2015 at 3:22pm
By Keith Coffman DENVER (Reuters) - The younger sister of Colorado movie massacre gunman James Holmes testified at his trial for the first time on Monday, telling jurors who will decide his fate that the murders were completely out of character, and she still loves him. Chris Holmes, 22, was called by the defense during the punishment phase of the trial.
Mylan independence from Teva's embrace comes with a price
27 Jul 2015 at 3:12pm
Teva announced a $40.5 billion deal for the generic assets of Allergan Plc after an unsuccessful three-month attempt to bring Mylan to the table. Mylan, whose shares fell 14.5 percent, said it would continue its own unsolicited pursuit of Irish drugmaker Perrigo Co, a maker of over-the-counter consumer and nutritional products and generic topical medicines. Perrigo is one of the few remaining assets out there," said Morningstar analyst Michael Waterhouse.
Planned Parenthood investigating claims of website hack
27 Jul 2015 at 2:54pm
Planned Parenthood called on the FBI and the U.S. Department of Justice on Monday for help managing cybersecurity, following a report that the reproductive healthcare group's website had been hacked by anti-abortion activists. The organization has come under scrutiny since the release of two secretly recorded videos earlier this month that critics said showed it was involved in the illegal sale of aborted fetal tissue for medical research. The Daily Dot online newspaper reported Monday that a hacking group had gained access to Planned Parenthood's website databases and the names and email addresses of its employees.
7 Tips to Staying Injury-Free
27 Jul 2015 at 2:38pm
Have you ever been just into your first set of lateral raises and felt a pinching feeling? What about being halfway through your run and your knee starts to hurt? What do you do? Do you press through or stop?There are very few of us that don't deal with injuries or niggles of some sort. So how can we prevent and manage injuries so that they...
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid
27 Jul 2015 at 2:29pm
Israel?s Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan?s generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential "transformational" acquisitions. The deal, the largest in Israel's corporate history, allows Teva stronger economies of scale, crucial in the low-margin generic drugs business. Teva, which dropped its hostile pursuit of Mylan, will likely have to sell off some drugs to allay antitrust concerns.
Allergan CEO, fresh off one deal, sets sights on others
27 Jul 2015 at 2:29pm
Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger. The readiness for a new transaction just after the Teva deal was announced on Monday represents what Saunders calls a strategy to remain nimble and open to opportunity as the healthcare sector remakes itself. Just last year, he helped orchestrate the $25 billion sale of Forest Laboratories Inc, where he was CEO, to Actavis Plc.